Treating huntingtin's disease using CRISPR/Cas9 gene editing: designing multiple sgRNA using in-silico tools
- At: Seville (Spain) (2022)
- Type: Poster
- Poster code: HMI-038
- By: R G, Sai Chaitanya (CMR College Of Pharmacy, India)
- Co-author(s): Mr Sai Chaitanya R G, Undergraduate Student (CMR College Of Pharmacy, Hyderabad, India)
Dr. Geetha Karra, Pharmaceutics (CMR College Of Pharmacy, Hyderabad, India)
Background information: CRISPR/Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR Associated endonucleases) is naturally a defence mechanism of Bacteria against Bacteriophages. It is a simple yet potential tool of biotechnology in gene editing. In recent times, researchers are inclining toward this tool as it has more.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.